The, "Global Biotechnology Reagent Market Research Report 2016" by OBRC, is a thorough study on current state of the biotechnology reagent market. The research report contains a simple outline of the industry covering definitions, classifications, applications and industry structure. The conspectus is professionally researched and enunciated for the international markets gives an insight of the market via competitive landscape analysis, development trends and significant regionals analysis. Forthcoming and existing development plans and policies are studied, including manufacturing operations and cost framework.

Reagent is a compound or substance or a mixture of substance, used in testing of another compound or substance by chemical reaction. Depending on the composition of the compound or substance reagent can be organic or inorganic in nature. Examples of organic reagent include Collins reagent and Fenton’s reagent. Acetone, potassium dichromate and thionyl chloride are some examples of inorganic reagents. Reagents in biotechnology are used in diagnosis, research, education, training, and healthcare.

The global biotechnology reagents market is expected to reach above $94.6 billion in 2022 and is anticipated to grow at a CAGR of 9.0% between periods 2016 and 2022.

Increasing R&D expenditure on biotechnology sector, growing number of biotechnology firms, growth in biopharmaceuticals, new upcoming technology andrising protein profiling are some of the drivers of the global biotechnology reagents market.  According to research journal Nature, the biotechnology research & development investment has jumped to $40.1billion in 2015 up 16% from $34.5billion in 2014.

Biopharmaceuticals is one of the promising sectors aligning biotechnology. Biopharmaceuticals manufacture healthcare drugs produced using biotechnology process. Biopharmaceutical products involve proteins like antibodies, nucleic acids like DNA, RNA, olignonucleotides, which are later used in therapeutic and in vivo diagnostic purposes. Recombinant human insulin is one of the first and common biopharmaceuticals product produced today. Oncology, anti-viral and auto immune disorders are poised for greatest growth in biopharmaceuticals in coming years. It is estimated that speciality and biologic drugs will make up half of healthcare industry by 2022.  Opportunities in biotechnology reagent market for the forecasted period are stem cells research and environmental biotechnology research. 

Varying regulatory environment in different countries and high cost of biopharmaceuticals are the factors hindering the growth of global biotechnology reagents market for the forecasted period.

The research report is segmented in terms of technology and application. Technology is further sub segmented into life science reagents and analytical reagents. Life science reagents is further classified into PCR, cell culture, IVD, and express & transfection. Analytical reagents is further sub segmented into chromatography, mass spectrometry, electrophoresis, and flow Cytometry.  PCR is classified into master mixtures and PCR reagent kits. Cell culture is further divided into sera and media & reagents. IVD is categorized as microbiology culture, haematology, immunoassay, clinical chemistry, and molecular diagnostics. Analytical Reagents is sub segmented into chromatography, mass spectrometry, and flow Cytometry. Application sub segmentation is carried out as gene expression, DNA & RNA analysis, drug testing, and protein synthesis & purification.

Some of the leading companies in global biotechnology reagent market are, Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter Inc., Becton Dickinson and Company, Biomerieux, Bio-Rad Laboratories Inc., GE Healthcare, Hoefer Inc., Life Technologies Corporation, Lonza Group Ltd, Meridian Biosciences Inc., Merck Milipore, Perkinelmer, Sigma Aldrich Corporation, and  Quality Biological Inc. The report provides comprehensive information like company profile, sales, revenue, market share and contact information.

Joint ventures, agreements, partnerships, collaborations, expansion in different countries, and strengthening supply chain network with distributors are some of the strategies taken by pioneers in biotechnology reagent market, to increase their global presence. Research & development investments are high with the urge to develop quality and environmental friendly products. Small biotechnology firms with unique and differentiated assets are driving innovation in biotechnology reagents market.

Merck Millipore on 13^th September 2016 got ISO/IEC-17025:2005 accreditation for quality control of the labs ReadyPlate^TMand ReadyTube^TM culture media. GE Healthcare on 30^th September 2016 announced Sefia, a multi-function platform which uses a combination of continuous flow centrifugation, fluidic management and temperature control during cell processing.  Sefia also features GE’s CT 800.1 kit used in cell processing.

The research report analysed biotechnology reagents market geographically. Region wise the report is segmented as North America, Europe, Asia Pacific, and Rest of the World.

North America is the largest market for biotechnology reagents followed by Europe and Asia Pacific. Innovation of new products, government policies & initiatives, positive regulatory environment, sound healthcare sector, and large investments in biotechnology research are the factors driving the North American market. U.S. is projected as the fastest growing market for biotechnology reagents for the forecasted period,following the completion of human genome project successfully and growingdemand of reagents for molecular biology. 

Investments in research & development both at university and industrial level has fuelled the growth of biotechnology reagent market in Europe. Asia Pacific biotechnology reagent market is projected to grow further with increasing outsourcing jobs in life science, investments in research & development and emerging local players following healthy economic outlook.

Request for Sample